Intra-abdominal Infection Clinical Trial
Official title:
Adjuvant Use of Autologous Platelet-rich Fibrin Glue in the Treatment of Fistulas and Anastomotic Leakages of the Digestive Tract
Adjuvant use of fibrin glue in the fistula tract may promote healing in low-output enterocutaneous fistulas. However, there are only few studies that report autologous glue application in a larger patient group or clinical-controlled studies in this setting. The aim of this study was to investigate the efficacy and safety of autologous platelet-rich fibrin glue (PRFG) in the treatment of low-output digestive fistulas and compare them with conservative management without the use of adjuvant application of FG into the fistulous tract.
Status | Completed |
Enrollment | 122 |
Est. completion date | January 2012 |
Est. primary completion date | January 2012 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years to 75 Years |
Eligibility |
Inclusion Criteria: - older than 18 years - presence of one or more fistulas - fistulas of low-output volume (< 200ml/24h) Exclusion Criteria: - failure to meet inclusion criteria - mental handicap - extreme thinness - fistulous tract length < 2 cm - fistulous tract diameter > 1 cm - entero-atmospheric fistulas - Crohn's disease-related fistulas - any conditions that might impede spontaneous closure of the fistula, such as complex tracts, associated abscesses, residual disease, foreign bodies or distal obstruction - any conditions that might increase the risk of auto-transfusion, including hypertension, or diabetes; and acquired immune deficiency syndrome (AIDS) |
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
China | Department of Surgery, Jinling Hospital | Nanjing | Jiangsu |
Lead Sponsor | Collaborator |
---|---|
Jinling Hospital, China |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | counting time from enrollment or glue application to fistula closure or healing (d) | The primary measures were defined as the time required for fistula closure and also fistula healing after the last treatment received if in study group, or since enrollment if in control group. Closure was predefined as the absence of drainage through the external openings whether occurring spontaneously or under externally applied pressure. Healing was predefined as complete reepithelialization of external openings. | 1-90 days | No |
Secondary | counting time from enrollment or glue application to enteral intake (d) | For secondary analyses, the time required to resume enteral intake from parenteral nutrition was collected. The hospitalization after enrollment, and also the proportion of patients with recurrence of a healed fistula during 12 months follow-up were evaluated. The incidence of adverse events and severe adverse events (defined as an event that was fatal or life-threatening, led to hospitalization or disability, or required an intervention to prevent one of these outcomes) was determined at each study visit. | 1-90 days | Yes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT06304779 -
The Effect of Continuous Intravenous Infusion of Lidocaine on PPCs and Prognosis in Emergency Surgical Patients With IAI
|
N/A | |
Completed |
NCT00230971 -
Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection (cIAI)
|
Phase 4 | |
Completed |
NCT05549076 -
Hellenic Registry for cIAIs (HERCO-II)
|
||
Suspended |
NCT04519086 -
The Optimization of a Low-dose CT Protocol in Patients With Suspected Uncomplicated Acute Appendicitis and BMI >30
|
N/A | |
Completed |
NCT01721408 -
A Study To Determine The Efficacy And Safety Of Tigecycline Compared With Imipenem/Cliastatin to Treat Complicated Intra-Abdominal Infection
|
Phase 4 | |
Completed |
NCT00621192 -
Pharmacokinetic (PK) and Safety Study of Meropenem in Young Infants With Intra-abdominal Infections
|
Phase 1/Phase 2 | |
Completed |
NCT02533869 -
The Optimization of a Low-dose Computed Tomography Protocol in Patients With Suspected Uncomplicated Acute Appendicitis
|
N/A | |
Completed |
NCT00952796 -
A Comparative Study of Ampicillin/Sulbactam Versus Moxifloxacin in the Treatment of Complicated Intra-abdominal Infections
|
Phase 4 | |
Completed |
NCT00630513 -
T.E.A. Study Three Days Ertapenem Versus Three Days Ampicillin- Sulbactam
|
Phase 4 | |
Completed |
NCT00488345 -
Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability of Tigecycline in Patients 8 to 11 Years of Age
|
Phase 2 | |
Completed |
NCT00481702 -
A Study to Evaluate the Safety and Effectiveness of Ertapenem Versus Ceftriaxone/Metronidazole in the Treatment of Intra-abdominal Infections in Adults (0826-802)
|
Phase 3 | |
Completed |
NCT04882085 -
Efficacy and Safety of CAZ-AVI in the Treatment of Infections Due to Carbapenem-resistant G- Pathogens in Chinese Adults
|
Phase 4 | |
Active, not recruiting |
NCT05187871 -
Study for Rapid Diagnosis of Postoperative Abdominal Infection
|
||
Completed |
NCT02739997 -
Study of Ceftolozane/Tazobactam (MK-7625A) in Combination With Metronidazole in Japanese Participants With Complicated Intra-abdominal Infection (MK-7625A-013)
|
Phase 3 | |
Recruiting |
NCT05127109 -
The PASTDUe Nutrition Ecosystem Project (PASTDUe)
|
Phase 4 | |
Not yet recruiting |
NCT04229511 -
Development of Risk Score Model and Decision Tree Algorithm for Predicting Infections With CRKp in Colonized Patients
|
||
Completed |
NCT00244088 -
Study Evaluating the Etiology of Intra-Abdominal Infections
|
N/A |